When was BioDtech founded?

BioDtech was founded in 2003 and raised its 1st funding round 4 years after it was founded.

Where is BioDtech located?

BioDtech is headquartered in Birmingham, United States.

How many employees does BioDtech have?

As of Jul 31, 2026, the latest employee count at BioDtech is 3.

Is BioDtech a funded company?

BioDtech is a funded company, having raised a total of $1.6M across 3 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Jul 01, 2007.

When was the latest funding round of BioDtech?

BioDtech's latest funding was a $***** Grant (prize money) round on Sep 01, 2014, with participation from 1 investor.

Where does BioDtech rank among its competitors?

BioDtech ranks 74th amongst 951 active competitors, of which 61 are funded. It stands 8th in terms of total funding among its competitors. The most recent competitor to raise funding was BioLamina, which secured $23.6M in Apr, 2026.

Who are the top competitors of BioDtech?

BioDtech's top competitors include Abcam, Meridian Bioscience and Enzo. Among them, BioLamina secured the most recent funding round in April, 2026.

BioDtech - 2026 Company Profile, Funding & Competitors

Company Details

BioDtech develops new technically superior products for the bioresearch and bioprocess markets for the detection, neutralization and removal of endotoxins. It offers reagents to develop assays for endotoxin detection and the ability to remove and neutralize endotoxin. It also provides services to detect and remove endotoxins from aqueous solutions using its EndoBind-R technology. It has negotiated a license agreement with the National University of Singapore for worldwide rights to develop these products.

Website: biodtechinc.com
Email ID: *****@biodtechinc.com

Key Metrics

Founded Year

2003

Location

Birmingham, United States

Stage

Acquired

Total Funding

$1.6M in 3 rounds

Latest Funding Round

Grant (prize money), Sep 01, 2014, $*****

Investors

Greer Capital Advisors & 3 more

Ranked

74^th among 951 active competitors

Employee Count

3 as on Jul 31, 2026

Similar Companies

Abcam & 1121 more

Exit Details

Acquired by Predictive Oncology (Jul 06, 2020)

View BioDtech's full profile

BioDtech got acquired by Predictive Oncology on Jul 06, 2020.

Click here to take a look at BioDtech's acquisition in detail

BioDtech has raised a total funding of $1.6M over 3 rounds. Its first funding round was on Jul 01, 2007. Its latest funding round was a Grant (prize money) round on Sep 01, 2014 for $*****. 1 investor participated in its latest round. BioDtech has 4 institutional investors.

Here is the list of recent funding rounds of BioDtech:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Sep 01, 2014	7139882	Grant (prize money)	4266994	2295060	4217456	1922149
Aug 25, 2010	3552113	Seed	7454377	9071157	9431487	8970691
Jul 01, 2007	4911696	Seed	4818688	5082075	Greer Capital Advisors	8313988

Access funding benchmarks and valuations. Sign up today!

View details of BioDtech's funding rounds and investors

BioDtech's employee count trend

BioDtech has 3 employees as of Jul 26. Here is BioDtech's employee count trend over the years:

Uncover BioDtech's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of BioDtech include Abcam, Meridian Bioscience and Enzo. Here is the list of Top 10 competitors of BioDtech, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Abcam 1998, Cambridge (United Kingdom), Acquired	Developer of biological reagents for life science research	$78.8M	Juno Investment Partners, Martlet Capital ... & 2 others	76/100
2nd	Meridian Bioscience 1976, Ohio (United States), Acquired	Molecular diagnostic device and kits	-	JobsOhio, NIH	65/100
3rd	Enzo 1976, Farmingdale (United States), Acquired	Life science products and services for research, drug discovery, and manufacturing	$7M	-	65/100
4th	Sino Biological 2007, Beijing (China), Series A	Provider of reagents,and kits for clinical research	$29.4M	Qiming Venture Partners, CTS Capital & 1 others	63/100
5th	Devyser 2004, Stockholm (Sweden), Public	Provider of molecular diagnostic kits for cancer, hereditary diseases, and reproductive disorders	$15.5M	Swedbank Robur, Fjarde AP-fonden & 1 others	61/100
6th	Huwel Life 2015, Hyderabad (India), Series A	Molecular diagnostic solutions and products for the healthcare industry	$5.74M	Bartronics, BIRAC & 3 others	59/100
7th	Miltenyi Biotec 1989, Bergisch Gladbach (Germany), Funding Raised	Develops tools and products for research and clinical application	-	Europa, HHS	58/100
8th	Stem Cell Technologies 1993, Vancouver (Canada), Series A	Developer of cell culture media and ancillary reagents for life science research	$11.9M	National Research Council Canada, Europa & 1 others	58/100
9th	BioIVT 1981, Westbury (United States), Acquired	Provider of in vitro diagnostic products and assay services	-	WILsquare Capital, Europa & 4 others	56/100
10th	BioLamina 2008, Sundbyberg (Sweden), Series B	Cell culture reagents for stem cell research	$18.2M	Lauxera Capital Partners, Bure Equity & 5 others	56/100
74th	BioDtech 2003, Birmingham (United States), Acquired	Develops technology products for the detection, neutralization and removal of endotoxins	$1.6M	Greer Capital Advisors, Targeted Technology ... & 2 others	38/100